The Body’s Inner Army: How Immunotherapy Trains the Immune System to Battle Cancer

Cancer immunotherapies are treatments that help a patient’s own immune system find and destroy cancer cells. Normally, the immune system might not recognize cancer cells as a threat, but these therapies condition or “train” immune cells to spot certain features – called antigens – that are found on cancer cells. Once trained, the immune cells work together to target and eliminate the cancer. There are different types of immune cells, each with their own job. Let’s look at some of these cell types and the role they play in immune system function. First Line of Defense: Monocytes, Macrophages, and Dendritic Cells Monocytes, macrophages, and dendritic cells are key immune cells that act as the body’s first line of defense, quickly detecting and neutralizing threats while also helping to activate the rest of the immune system for a more targeted response. Monocytes travel through the bloodstream and are quick to respond [...]

2025-06-03T12:53:26-06:00June 3rd, 2025|

One Health: Leveraging the Intersection of Health Across Our World

January is One Health Awareness Month, which recognizes and promotes the "interconnectedness of the health of people, animals, and the environment." (Forbes.)  ELIAS Animal Health was founded to apply the progress that has been made in fighting human cancers in the veterinary space, and then share the findings with our human health counterparts. We follow a collaborative, interdisciplinary approach, aligned with the One Health philosophy about the connections and correlations between the health of people, animals, and the environment. Human and canine cancers share similarities, so research on either side can impact and support the other: TVAX Biomedical is launching a glioblastoma study in the near future. ELIAS’ origins came from the early work and research conducted by TVAX.  TVAX and Genelux Corporation, a clinical stage immunotherapy company focused on developing oncolytic virus therapies for humans, have formed a joint venture known as V2ACT Therapeutics™, LLC that will focus on [...]

2023-01-24T12:56:03-06:00January 10th, 2023|
Go to Top